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OBJECTIVE: To assess the validity and reliability of the Brazilian Portuguese version of the Brief Assessment of
Cognition in Schizophrenia by examining its temporal stability, internal consistency, and discriminant and
convergent validity.
METHODS: The Brief Assessment of Cognition in Schizophrenia was administered to 116 stable patients with
schizophrenia and 58 matched control subjects. To assess concurrent validity, a subset of patients underwent a
traditional neuropsychological assessment.
RESULTS: The patients with schizophrenia performed significantly worse than the controls (po0.001) on all
subtests of the Brief Assessment of Cognition in Schizophrenia and on the total score, which attests to the
discriminant validity of the test. The global score of the Brief Assessment of Cognition in Schizophrenia was
significantly correlated with all of the subtests and with the global score for the standard battery. The Brief
Assessment of Cognition in Schizophrenia also had good test-retest reliability (rho40.8). The internal
consistency of the Brief Assessment of Cognition in Schizophrenia was high (Cronbach’s a =0.874).
CONCLUSION: The Brazilian Portuguese version of the Brief Assessment of Cognition in Schizophrenia exhibits good
reliability and discriminant and concurrent validity and is a promising tool for easily assessing cognitive impairment in
schizophrenia and for comparing the performance of Brazilian patients with that of patients from other countries.
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’ INTRODUCTION
In recent decades, several lines of evidence have shown
that cognitive impairment is a core feature of schizophrenia
and a major determinant of general functioning in patients
with schizophrenia. However, advances in this field have
been hampered by the lack of a specific instrument for
assessing cognition in schizophrenia that provides reliable
and comparable data. Recently, many efforts have helped fill
this gap. For example, the MATRICS is a US government
multi-site enterprise designed to elaborate and disseminate
instruments to assess cognition in schizophrenia for use in
drug trials (1,2). Other neuropsychological batteries specifi-
cally designed for schizophrenia have been proposed for
more general purposes (3–5).
The Brief Assessment of Cognition in Schizophrenia
(BACS) is a portable pen-and-paper battery that takes
approximately 40 min to administer and reliably assesses
the main cognitive domains affected in schizophrenia. The
BACS has been translated into and validated in several
languages, including French (6), Japanese (7), German (8),
Spanish (9), Italian (10) and Persian (11), making it an
appropriate instrument for internationally registering and
comparing data for both clinical and research purposes.
We translated the BACS from English to Portuguese, and
the back-translation was approved by the original author
(RK). We also performed a preliminary assessment of the
applicability and sensitivity of this Brazilian Portuguese
version of the BACS in a small sample of patients (12). TheDOI: 10.6061/clinics/2015(04)10
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aim of the present paper is to assess the validity and reliability
of the BACS by examining its temporal stability, internal
consistency, and discriminant and convergent validity.
’ METHOD
Subjects
One hundred sixteen (116) patients diagnosed with schizo-
phrenia and 58 control subjects were enrolled in this study.
The patients were recruited from the outpatient clinic at the
Raul Soares Institute, Belo Horizonte, Brazil. The inclusion
criteria for patients were as follows: meeting the DSM-IV
criteria for schizophrenia, having no history of brain trauma,
and not suffering from a current substance use disorder. The
psychiatric diagnosis was made according to a structured
clinical interview using the MINI-PLUS (13). To assure that
patients were stabilized for acute psychotic symptoms, only
patients who scored 4 or less on any item of the positive
subscale of the Positive and Negative Symptoms Scale
(PANSS) were enrolled in the study. Furthermore, the patients
needed a PANSS positive subscale score of less than 19 (14).
There were no specific medication criteria for inclusion in the
patient group. The control subjects were people from the
community and hospital staff members. They were required
to not have a DSM-IV Axis I disorder based on a structured
clinical interview (MINI-PLUS) or any relevant neurological
illness.
Instruments
Brazilian BACS. The adaptation of the BACS to Brazilian
Portuguese is described elsewhere (12). The constructs
measured with the Brazilian version of the BACS, including
the tests, procedures, and measures, are listed below in the
order of administration.
Verbal memory. The patients were presented with 15 words
and then asked to recall as many words as possible. This
procedure was repeated five times. There were two lists of
words (A and B), one for each version. Measure: The number
of words recalled per trial in any order (range: 0–75).
Working memory. Digit sequencing task: The patients were
presented with clusters of numbers of increasing length.
They were asked to tell the experimenter the numbers in
order, from lowest to highest. Measure: The number of
correct responses (range: 0–28).
Motor speed. Token motor task: The patients were given
100 plastic tokens and asked to place them two at a time into
a container as quickly as possible. A 60-s time limit was
imposed. Measures: the number of tokens correctly placed
into the container in the first half min, the second half min,
and the 1 min total (range: 0–100).
Verbal fluency. Semantic or category fluency: The patients
were given 60 s to name as many words as possible within a
given category (names of animals).
Phonetic or letter fluency: In two separate trials, the
patients were given 60 s to generate as many words as
possible that begin with a given letter (F, S). Measure: The
number of words generated per trial.
Attention and speed of information processing. Symbol
coding: As quickly as possible, the patients wrote the
numerals 1–9 as matches to symbols on a response sheet.
The patients had up to 90 s to complete the task. Measure:
The number of correct numerals (range: 0–110).
Reasoning and problem solving. Tower of London: The
patients were simultaneously shown two pictures. Each
picture showed three balls of different colors arranged on
three pegs, with the balls in a distinct arrangement in each
picture. The patients were asked to name the total number of
times the balls in one picture needed to be moved to arrange
them in the manner shown in the other picture. There were
20 trials. The items were of variable difficulty, with a general
tendency for latter items to be more difficult. The test was
discontinued if the patients gave five consecutive incorrect
responses. If the patients answered correctly for all 20 trials,
two additional trials of greater difficulty were administered.
There were two alternate forms on versions A and B.
Measure: The number of correct responses (range: 0–22).
Standard battery
The standard battery used for the traditional neuropsy-
chological assessment was the same one that was used to
validate the BACS in French (6). The battery was composed
of widely used tests that are thought to assess the same
constructs as the BACS. The tests and their respective
constructs are listed below in the order administered: The
Rey Auditory-Verbal Learning Test (verbal memory); the
Wechsler Adult Intelligence Scale, third edition, Digit Inverse
Coding and Digit Symbol-Coding subtests (working mem-
ory; attention and speed of information processing); Trail
Making A (motor speed), the Controlled Oral Word
Association Test; Category Instances (verbal fluency); and
the Wisconsin Card Sort Test - 128 card version (reasoning
and problem solving). All of the tests included in the
concurrent battery had been previously validated in
Brazilian Portuguese (15–17).
Design
To assess the discriminant validity of the BACS, all
patients and controls were randomly assigned to take either
Brazilian BACS version A or version B. To assess the
concurrent validity of the BACS, 30 patients were randomly
selected from the original sample and completed the
concurrent validity battery. This subgroup of patients did
not differ from the whole sample with regard to demo-
graphic and clinical characteristics. The interval between
these two assessments was approximately three weeks. To
assess the temporal stability of the BACS, 21 patients also
underwent a retest of the BACS. The interval between the
two assessments was approximately three months, and
the retest always used the alternate form (A or B). None of
the patients who took the concurrent test battery participated
in the temporal stability assessment. We also examined the
internal consistency of the BACS within individual patients.
Statistical analysis
We calculated the mean and standard deviation for each
subtest of the Brazilian Portuguese version of the BACS
(using a control group, n = 58) and for the standard battery
(n = 30) to obtain subtest z-scores, which were calculated as
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the subtest z-score = (subtest score - subtest mean) / (subtest
standard deviation). The sum of the respective subtest
z-scores of each battery was used as the global score.
The variables were processed in a database, and statistical
analyses were conducted using R software version
2.15.2 (18). We performed a principal component analysis
using the correlation matrix, and the first components of the
Brazilian Portuguese version of the BACS (116 patients) and
the standard battery (30 patients) were used as global scores.
Comparisons between the patient and control groups were
performed using independent t-tests. To assess concurrent
validity, the global scores of the Brazilian Portuguese version
of the BACS and the standard battery were compared using
the Spearman correlation. The test-retest analysis was
performed using the paired t-test and the Spearman
correlation. The internal consistency of the Brazilian Portu-
guese version of the BACS was assessed using Cronbach’s a.
Ethical aspects
This study was approved to the local Ethics Committee
and was conducted in accordance with the Code of Ethics
of the World Medical Association (Declaration of Helsinki).
All of the patients gave their informed consent, and their
anonymity was preserved.
’ RESULTS
The BACS required approximately 40 min for application
in both the patients and the controls. This administration
time is similar to that of other language versions of BACS
(3,6,19) and significantly shorter than that of the standard
battery, which required approximately 62 min to administer.
No patient or control dropped out of the test during the
session, suggesting that the BACS is feasible for administer-
ing to Brazilian patients.
Table 1 shows the demographics data and BACS perfor-
mance of the controls and patients. The BACS global score
and the scores for all of the subtests were significantly worse
in the patient group compared with the controls.
To assess concurrent validity, we compared the global
BACS scores with the scores for the standard battery. The
global scores of the two batteries were significantly
correlated (Spearman’s rho=0.625, p-value=0.0003, N=30).
The BACS global scores were significantly correlated
(p-valueo10-10) with each of the test constructs. The results
are shown in Table 2.
In the test-retest analysis (Table 3), all of the BACS items
for the first test were significantly correlated (Spearman’s
rho40.6, p-valueo0.002) with the same items on the second
test. The intraclass correlation coefficients (two-way mixed
single variables) were higher than 0.7 and were significant
(p-valueo0.002) for every BACS item and also for the global
score. There was no significant change in the mean score of
any item (changeo0.31 standard deviation, p-value40.15).
The Cronbach’s a of the BACS battery was 0.874, indicating
a very good internal consistency. The principal component
analysis showed that the first component explained 57.4% of
the variance, while the second component explained only
11.3% of the variance. The first component also correlated
significantly with each of the test constructs (Spearman’s
rho40.55, p-valueo10 10). In the standard battery, the first
component explained 41.7% of the variance, while the second
components explained 17.6% of the variance. These results
suggest that a one-factor solution best fits our data.
’ DISCUSSION
The patients with schizophrenia performed significantly
worse than the controls on all subtests of the BACS and on
the total score. This result was similar to those of the original
English version and other language versions of the test and
attests to the discriminant validity of the test. Importantly,
unlike the subjects in the English and Spanish studies, our
Table 1 - Comparison of the demographic variables and the performance on the Brazilian Portuguese version of the
BACS between patients and controls
Variable Patient mean (N=116) Control mean (N=58) p-value (x2/t-test)
Demographics Gender – Male (%) 51.7 46.6 0.52
Age (years) 38.5 39.1 0.78
Education (years) 8.02 7.62 0.52
BACS subtest Test duration (min) 40.7 39.5 0.36
Verbal memory 28.64 39.62 o0.001
Digit sequencing 10.98 16.79 o0.001
Token motor 51.00 72.19 o0.001
Verbal fluency - Semantic 14.04 19.22 o0.001
Verbal fluency - Phonetic 17.28 25.74 o0.001
Symbol coding 24.12 40.98 o0.001
Tower of London 10.10 13.65 o0.001
Global score w 0.0 2.93 o0.001
w
Global score = principal component analysis score (116 patients).
Table 2 - Correlations of the global scores for the Brazilian
Portuguese version of the BACSw with each construct and
with the standard battery global scores.
Spearman’s correlation
with BACS global scoresw
p- value
BACS subtests (N=116)
Verbal memory 0.729 o10 10
Digit sequencing 0.761 o10 10
Token motor 0.558 o10 10
Verbal fluency - Semantic 0.742 o10 10
Verbal fluency – Phonetic 0.761 o10 10
Symbol coding 0.797 o10 10
Tower of London 0.739 o10 10
Standard battery global scores=
(N = 30)
0.625 0.0003
w
BACS global score = Principal component analysis score (116 patients).
=Standard battery global score = Principal component analysis score
(30 patients).
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controls did not differ from the patients in terms of age,
gender or years of education (3,9).
This study also showed the concurrent validity of the BACS
because its global score was significantly correlated with the
scores of all subtests and the global score of a standard battery.
All of the correlations were high (rho40.7) except for those of
the global score and the motor speed, which showed lower
correlations (rho=0.625 and 0.558, respectively). Similar results
for the motor speed subtest were found for our study and the
English, French and German versions of the BACS (3,6,8).
The BACS also had good test-retest reliability because its
global score showed a very high correlation between the test
and retest sessions (rho40.8). Most of the subtests also
showed high correlations (rho40.7) between test and retest,
although working memory and verbal memory showed only
moderate (rho40.6) correlations. These results are similar to
those of the original BACS (3) and of all of the versions
(German, Japanese, and Persian) that have been tested for
temporal stability (7,8,11); together, they confirm that the
BACS scores seem to be stable over time.
The high internal consistency of the BACS is comparable to
that of the original English and the Japanese and Persian
versions (3,7,11).
Our principal component analysis showed that the first
component explained 57.4% of the variance. The first
component also correlated significantly with each of the test
constructs, suggesting that a one-factor solution best fits our
data. The same solution was obtained in our pilot study of the
BACS (12) and in studies of the Spanish and Persian versions
(9,11), while the French version found a two-factor solution
(6), and the original test in English and the Japanese version
found a three-factor solution (3,7). This variance in the
component analysis among these studies may be related to
the differences in their samples (9).
This study has some limitations. The sample size used in
the test-retest analysis was small, and their results should be
interpreted with caution despite the very high correlation
observed between test and retest.
The BACS was able to differentiate schizophrenic patients
from the control group and had good test-retest reliability,
concurrent validity, and internal consistency. Additionally, a
representative global score of the test was obtained using
principal component analysis, suggesting that the test has a
one-factor structure. The BACS seems to be an easy and fast
neuropsychological tool for assessing global cognition in
Brazilian patients with schizophrenia.
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